Delivery Order SPE2DB22D1106-SPE2DB24FFJZ1
Award Date 8/27/24
Potential Completion Date 9/18/24
Potential Value $5.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,947.85, is a Firm Fixed Price Delivery Order for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a completion date of February 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a type of pharmaceutical product, with a ceiling value of $5,263.74. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 16, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The $10,527.36 contract has a period of performance through May 9, 2024. AmerisourceBergen is a major pharmaceutical distributor providing a wide range of medical commodities to federal agencies, particularly supporting military and veterans' healthcare programs through large Indefinite Delivery...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,565,606,804 units of the pharmaceutical product ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a firm fixed price ceiling value of $1,754.58 and an ultimate completion date of September 17, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this delivery order contract without any set-aside...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product, with a ceiling value of $5,578.50. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award date is June 13, 2025, and the ultimate completion date is July 8, 2025. The place of performance is Conshohocken, PA. This...
- This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDVL2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,380.94, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product. The contract does not have a set-aside designation, indicating open competition. It is a Delivery Order contract with a Firm Fixed Price pricing type, with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at up to $5,263.74, is a delivery order for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of June 21, 2024. Amerisourcebergen Drug Corporation is a major pharmaceutical distribution company that holds a significant Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,873.74 firm fixed price delivery order is for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a completion date of February 13, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received multiple awards from DLA Troop Support Medical to supply...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,754.58 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, with a completion date of March 15, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, which has a potential value of $999,999,999.00 and a performance period...
- This is a Delivery Order (DO) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,303.52, is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of April 10, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...